Cargando…

The Potential and Limitations of Precision Oncology: Lessons Learned from Whole-Exome Sequencing in an Exceptional Response to Everolimus in Advanced Renal Cell Carcinoma

Through elucidating the genetic mechanisms of drug sensitivity, precision medicine aims to improve patient selection and response to therapy. Exceptional responders are patients that exhibit exquisite and durable responses to targeted therapy, providing a rare opportunity to identify the molecular b...

Descripción completa

Detalles Bibliográficos
Autores principales:	Pilling, Amanda, Wee, Christopher, Bar-Meir, Eliezer, Dyson, Gregory, Hwang, Ok, Gupta, Nilesh, Chitale, Dhananjay, Hwang, Clara
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	S. Karger AG 2021
Materias:	Case Report
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8460888/ https://www.ncbi.nlm.nih.gov/pubmed/34703436 http://dx.doi.org/10.1159/000516277

Ejemplares similares

Immune monitoring technology primer: whole exome sequencing for neoantigen discovery and precision oncology
por: Kvistborg, Pia, et al.
Publicado: (2016)

Whole Exome Sequencing of Thymoma Patients Exhibiting Exceptional Responses to Pemetrexed Monotherapy
por: Tanaka, Tomohiro, et al.
Publicado: (2023)

Next-generation sequencing reveals somatic mutations that confer exceptional response to everolimus
por: Lim, Sun Min, et al.
Publicado: (2016)

Precision oncology: lessons learned and challenges for the future
por: Yang, Hsih-Te, et al.
Publicado: (2019)

Exome sequencing of three cases of familial exceptional longevity
por: Cash, Timothy P, et al.
Publicado: (2014)

Exceptional durable response to everolimus in a patient with biphenotypic breast cancer harboring an STK11 variant
por: Parachoniak, Christine A., et al.
Publicado: (2017)

Integration of whole-exome and anchored PCR-based next generation sequencing significantly increases detection of actionable alterations in precision oncology
por: Beg, Shaham, et al.
Publicado: (2020)

Pharmacokinetic Optimization of Everolimus Dosing in Oncology: A Randomized Crossover Trial
por: Verheijen, Remy B., et al.
Publicado: (2017)

A comparative assessment of clinical whole exome and transcriptome profiling across sequencing centers: implications for precision cancer medicine
por: Van Allen, Eliezer M., et al.
Publicado: (2016)

PET/CT Imaging in Oncology: Exceptions That Prove the Rule
por: Casali, M., et al.
Publicado: (2013)

Exceptional response to everolimus in a novel tuberous sclerosis complex-2 mutation–associated metastatic renal-cell carcinoma
por: Alsidawi, Samer, et al.
Publicado: (2018)

Exceptional Response to Everolimus in a Patient with Metastatic Castrate-Resistant Prostate Cancer Harboring a PTEN Inactivating Mutation
por: Kmak, Jamie A., et al.
Publicado: (2020)

Whole-exome sequencing and clinical interpretation of FFPE tumor samples to guide precision cancer medicine
por: Allen, Eliezer M. Van, et al.
Publicado: (2014)

Precision Oncology in Canada: Converting Vision to Reality with Lessons from International Programs
por: Liu, Geoffrey, et al.
Publicado: (2022)

Racial and Ethnic Disparities Among Participants in Precision Oncology Clinical Studies
por: Aldrighetti, Christopher M., et al.
Publicado: (2021)

Whole-exome sequencing of long-term, never relapse exceptional responders of trastuzumab-treated HER2+ metastatic breast cancer
por: Walsh, Naomi, et al.
Publicado: (2020)

Clinicopathological features of pseudomyogenic hemangioendothelioma and precision therapy based on whole exome sequencing
por: Wei, Junqiang, et al.
Publicado: (2020)

Lessons learnt from prenatal exome sequencing
por: Chandler, Natalie J., et al.
Publicado: (2022)

Targeting prosurvival BCL2 signaling through Akt blockade sensitizes castration‐resistant prostate cancer cells to enzalutamide
por: Pilling, Amanda B., et al.
Publicado: (2019)

Comprehensive Outline of Whole Exome Sequencing Data Analysis Tools Available in Clinical Oncology
por: Bartha, Áron, et al.
Publicado: (2019)

Model-Informed Precision Dosing of Everolimus: External Validation in Adult Renal Transplant Recipients
por: Zwart, Tom C., et al.
Publicado: (2020)

Exceptional vascular variants during oncological right colectomy: Case reports
por: Landolsi, Sana, et al.
Publicado: (2023)

Actionability and precision oncology
por: Schwaederle, Maria, et al.
Publicado: (2015)

Bioinformatics for precision oncology
por: Singer, Jochen, et al.
Publicado: (2017)

The Future of Precision Oncology
por: Rulten, Stuart L., et al.
Publicado: (2023)

Vorolanib and everolimus: Lenvatinib and everolimus part deux, or something new?
por: Chehrazi-Raffle, Alexander, et al.
Publicado: (2020)

Genetic Testing of Korean Familial Hypercholesterolemia Using Whole-Exome Sequencing
por: Han, Soo Min, et al.
Publicado: (2015)

An Emerging Role for Radiation Oncology in Precision Oncology
por: Goyal, Sharad, et al.
Publicado: (2016)

Exceptional responses to PARP inhibitors in patients with metastatic breast cancer in oncologic crisis
por: Cheng, Joyce M., et al.
Publicado: (2023)

From N-of-one to series of exceptional responders: unlocking the mystery of outliers in oncology
por: Rodriguez, Julieta E., et al.
Publicado: (2023)

A Silent Corticotroph Pituitary Carcinoma: Lessons From an Exceptional Case Report
por: Remón-Ruiz, Pablo, et al.
Publicado: (2021)

Cultural Competence—Lessons From an Exceptional Case of Care Delivery to My Mom
por: Denbow-Burke, Orrisha, et al.
Publicado: (2022)

Androgen receptor negatively regulates mitotic checkpoint signaling to induce docetaxel resistance in castration‐resistant prostate cancer
por: Pilling, Amanda, et al.
Publicado: (2021)

Synergic Effect of Metformin and Everolimus on Mitochondrial Dynamics of Renal Cell Carcinoma
por: Hong, Seong-Hwi, et al.
Publicado: (2022)

Whole‐exome sequencing for variant discovery in blepharospasm
por: Tian, Jun, et al.
Publicado: (2018)

Racial and ethnic disparities in a real-world precision oncology data registry
por: Cheung, Alexander T. M., et al.
Publicado: (2023)

Loss of Let-7 Up-Regulates EZH2 in Prostate Cancer Consistent with the Acquisition of Cancer Stem Cell Signatures That Are Attenuated by BR-DIM
por: Kong, Dejuan, et al.
Publicado: (2012)

An exceptional vaccination policy in exceptional circumstances
por: The Lancet Infectious Diseases
Publicado: (2021)

Evaluation of Whole-Exome Enrichment Solutions: Lessons from the High-End of the Short-Read Sequencing Scale
por: Díaz-de Usera, Ana, et al.
Publicado: (2020)

International Association of Contact Lens Educators: Exceptional education— Exponential impact
por: Shinde, Lakshmi, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_kegupqi3ou5aq1i65kodk8j5o7